Trulicity 3 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV835
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,022
Award facts
- Contract value 100% obligated
- $31,022.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,022.26 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml doses), with completion expected by January 29, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's significant IDC with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The IDC encompasses a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Trulicity, a diabetes medication, exemplifies the company's role in delivering critical pharmaceuticals to support Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen's consistent receipt of non-set-aside competitive awards demonstrates its capability to meet rigorous federal procurement standards for essential medical commodities.
Quick answers
Who was awarded contract SPE2DR26FV835?
SPE2DR26FV835 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FV835 worth?
The government has obligated $31,022 on SPE2DR26FV835.
Is contract SPE2DR26FV835 an order under another contract?
Yes. SPE2DR26FV835 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV835 competed?
The extent of competition for SPE2DR26FV835 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award